1. Home
  2. List
Reference Patent

Reference - List

  • 30 Hits
  • Search Condition : Filter (MeSH = Lung Neoplasms* / pathology)
Species Resource Title
Human and Animal Cells A549(RCB0098) Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics.
Human and Animal Cells A549(RCB0098) Plasma-activated medium ameliorates the chemoresistance of human lung adenocarcinoma cells mediated via downregulation of claudin-2 expression.
Human and Animal Cells A549(RCB0098) Propranolol and landiolol inhibit cell proliferation enhanced by noradrenaline in human lung adenocarcinoma cells.
Human and Animal Cells Saos-2(RCB0428) Lung fibrosis is a novel therapeutic target to suppress lung metastasis of osteosarcoma.
Human and Animal Cells EBC-1(RCB1965) PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
Human and Animal Cells PC-9(RCB4455) Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
Human and Animal Cells Ba/F3-CL1(RCB4474) Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.
Human and Animal Cells THP-1(RCB1189) Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway.
Human and Animal Cells LM8(RCB1450) Inhibitory effect of aspirin on inflammation-induced lung metastasis of cancer cells associated with neutrophil infiltration.
Human and Animal Cells II-18(RCB2093) Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
Human and Animal Cells ACC-MESO-4(RCB2293) , Y-MESO-14(RCB5668) POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.
Human and Animal Cells ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) , HMMME(RCB0819) Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma.
Human and Animal Cells Ba/F3(RCB0805) The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics.
Human and Animal Cells , DNA material II-18(RCB2093) , tFucci(CA)2/pCSII-EF (RDB15446) L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.
Human and Animal Cells A549 Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer.
Human and Animal Cells LC-2/ad(RCB0440) Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
Human and Animal Cells Lu99(RCB1900) , LU65(RCB1967) Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
Human and Animal Cells A549(RCB0098) Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.
Yeast Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors.